OUR BLOG – List style
Latest Updates & News
At vero eos et accusamus iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos at dolores molestias excepturi sint occaecati cupiditate.
FDA Warning Letter Says Products Sold as Exosomes May Not Contain Exosomes
An August 2026 FDA warning letter to R3 Medical Companies finds that products marketed as exosomes were made by a process that does not appear would isolate exosomes. What that means for practitioners who buy regenerative biologics.
Exosome Therapy for Frozen Shoulder: What the Evidence Actually Shows
Frozen shoulder is a fibrotic contracture of the joint capsule, not a tendon injury. What MSC-derived exosomes are thought to do to capsular fibrosis, and how strong that evidence is in 2026.
Exosomes for Diabetic Foot Ulcers: What the First Randomized Trial Actually Showed
A randomized controlled trial of Wharton’s jelly MSC exosomes in 110 chronic diabetic foot ulcer patients, read alongside a 2026 preclinical meta-analysis. What the data support, and what it does not.
Exosome Therapy for Sciatica: What the 2026 Evidence Actually Shows
Sciatica is driven by inflammation at the nerve root as much as by compression. Here is how MSC-derived exosomes are thought to act, and an honest read of the 2026 human evidence.
Regenerative Medicine in Salt Lake City: Exosome Therapy, Stem Cells & Peptide Treatments
Exosome therapy, stem cells, PRP and peptides in Salt Lake City. Real costs, what the evidence shows, FDA status, and how to vet a Wasatch Front clinic.
Exosome Storage and Handling: What the Cold Chain Does to Product Quality
What 50 pooled studies say about exosome storage and handling: minus 80 storage, freeze-thaw damage, formulation, and the questions to ask a supplier.
Exosome Dosing: What 66 Clinical Trials Say About Getting the Number Right
A review of 66 registered MSC-derived extracellular vesicle trials finds that route of delivery, not volume, sets the effective dose, and that only six trials reported enough detail to analyse dose at all.
Exosome Therapy vs. Hyaluronic Acid Injections for Knee Osteoarthritis
One option has decades of human trials and guideline bodies recommending against routine use. The other has promising biology and almost no controlled human data. Here is how to weigh exosome therapy against hyaluronic acid injections for knee osteoarthritis.
Regenerative Medicine in New Orleans: Exosome Therapy, Stem Cells & Peptide Treatments
Exosome therapy, stem cells, PRP and peptides in New Orleans. Real costs, what the evidence shows, FDA status, and how to vet a clinic.
Exosome Therapy for Achilles Tendinopathy: What the Evidence Actually Shows
Exosome therapy for Achilles tendinopathy is heavily marketed and thinly evidenced. Here is what the biology suggests, what the published research has and has not established, and how to evaluate the option.